These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1748786)

  • 1. Platelet adhesiveness in diabetes mellitus with relation to treatment.
    Samal KK; Sahu CS; Nanda RC
    J Indian Med Assoc; 1991 Jun; 89(6):155-7. PubMed ID: 1748786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of dyslipidemia and platelet adhesiveness in non-insulin dependent diabetes mellitus.
    Kurhade GA; Waghmare P; Phatak MS; Gosavi GB
    Indian J Physiol Pharmacol; 2000 Apr; 44(2):167-72. PubMed ID: 10846630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indirect evidence of impairment of platelet desaturase enzymes in diabetes mellitus.
    Jones DB; Carter RD; Mann JI
    Horm Metab Res; 1986 May; 18(5):341-4. PubMed ID: 3013745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of acarbose on postprandial increase in blood glucose. Additive acute effect of once daily administration in insulin treated diabetes].
    Ledermann H; Höxter G
    Fortschr Med; 1994 Nov; 112(32):467-70. PubMed ID: 7821886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Incidence of severe hypoglycemia in relation to metabolic control and patient knowledge].
    Ratzmann KP; Schimke E
    Med Klin (Munich); 1995 Oct; 90(10):557-61. PubMed ID: 7500918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meal-induced platelet activation in Type 2 diabetes mellitus: effects of treatment with repaglinide and glibenclamide.
    Yngen M; Ostenson CG; Hjemdahl P; Wallén NH
    Diabet Med; 2006 Feb; 23(2):134-40. PubMed ID: 16433710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated plasma levels of the atherogenic mediator soluble CD40 ligand in diabetic patients: a novel target of thiazolidinediones.
    Varo N; Vicent D; Libby P; Nuzzo R; Calle-Pascual AL; Bernal MR; Fernández-Cruz A; Veves A; Jarolim P; Varo JJ; Goldfine A; Horton E; Schönbeck U
    Circulation; 2003 Jun; 107(21):2664-9. PubMed ID: 12742991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diabetes mellitus and platelet half-life].
    Banfi L; Vecchi C; Galetti A; Giussani R; Guzzini F
    Clin Ter; 1987 May; 121(4):305-10. PubMed ID: 2973867
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners].
    Fabian W; Majkowska L; Stefański A; Moleda P
    Przegl Lek; 2005; 62(4):201-5. PubMed ID: 16229234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet adhesiveness in diabetes mellitus with and without vascular complications.
    Ramani A; Kumar S; Tyagi N
    J Assoc Physicians India; 1986 Nov; 34(11):792-3. PubMed ID: 3558304
    [No Abstract]   [Full Text] [Related]  

  • 11. Nicotinamide effects oxidative burst activity of neutrophils in patients with poorly controlled type 2 diabetes mellitus.
    Osar Z; Samanci T; Demirel GY; Damci T; Ilkova H
    Exp Diabesity Res; 2004; 5(2):155-62. PubMed ID: 15203886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet aggregation, platelet cAMP levels and thromboxane B2 synthesis in patients with diabetes mellitus.
    Chen SY; Yu BJ; Liang YQ; Lin WD
    Chin Med J (Engl); 1990 Apr; 103(4):312-8. PubMed ID: 2167823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium transport across erythrocyte membranes in diabetes mellitus.
    Jennings PE; Wilkins MR; West MJ; Kendall MJ; Barnett AH
    Diabetes Res; 1986 Oct; 3(8):407-10. PubMed ID: 3028693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of pioglitazone and metformin on plasma adiponectin in newly detected type 2 diabetes mellitus.
    Sharma PK; Bhansali A; Sialy R; Malhotra S; Pandhi P
    Clin Endocrinol (Oxf); 2006 Dec; 65(6):722-8. PubMed ID: 17121522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circadian variations in plasma immunoreactive insulin (IRI) and C-peptide concentrations in adult onset (type II) diabetes mellitus.
    Nicolau GY; Haus E; Lakatua DJ; Bogdan C; Petrescu E; Sackett-Lundeen L; Stelea S; Stelea P
    Endocrinologie; 1984; 22(1):3-16. PubMed ID: 6369501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assisting effects of lithium on hypoglycemic treatment in patients with diabetes.
    Hu M; Wu H; Chao C
    Biol Trace Elem Res; 1997; 60(1-2):131-7. PubMed ID: 9404682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of lipid profiles and lipoprotein a levels in patients with type 2 diabetes mellitus during oral hypoglycemic or insulin therapy.
    Habib SS; Aslam M; Naveed AK; Razi MS
    Saudi Med J; 2006 Feb; 27(2):174-80. PubMed ID: 16501671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous glucose monitoring: physiologic and pathophysiologic significance.
    Ionescu-Tîrgovişte C; Guja C; Ioacără S; Dumitrescu D; Tomescu I
    Rom J Intern Med; 2004; 42(2):381-93. PubMed ID: 15529628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of dietary fibre on platelet adhesiveness.
    Khan HS; Siddiqui MA; Mittal AK; Ajmal MR
    J Assoc Physicians India; 1990 Mar; 38(3):219-20. PubMed ID: 2167886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet factor 4 (PF4) and heparin released platelet factor 4 (HR-PF4) in diabetes mellitus. Effect of the duration of the disease.
    Cella G; Scattolo N; Vio C; Stevanato F; Lavagnini T; Padovan D; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):646-54. PubMed ID: 2435630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.